コールドチェーン医薬品市場：医薬品、サービス、温度範囲、輸送-2025-2030年世界予測

コールドチェーン医薬品市場は、2023年に78億9,000万米ドルと評価され、2024年には88億5,000万米ドルに達すると予測され、CAGR 12.65%で成長し、2030年には181億8,000万米ドルに達すると予測されています。

コールドチェーン医薬品市場には、医薬品を指定された低温に維持するために設計された物流、保管、輸送システムが含まれます。その必要性は、温度に敏感な医薬品、ワクチン、生物製剤の有効性と品質を維持することに根ざしています。重要な用途には、ワクチン流通、バイオ医薬品、臨床試験材料などがあり、エンドユーザーは病院から研究所、小売薬局まで多岐にわたる。同市場は、バイオ医薬品や複雑な生物製剤に対する世界の需要の増加と、規制遵守や品質基準への関心の高まりにより、大幅な成長が見込まれています。慢性疾患の有病率の上昇と予防接種の世界の推進は、リアルタイムのデータ追跡と予測分析を支援するIoTとAIを搭載したモニタリングシステムの技術的進歩とともに、この成長に大きく寄与しています。しかし、この分野は、高い運用コスト、発展途上地域の限られたインフラ、厳しい規制状況などの制約に直面しており、シームレスな拡大への課題となっています。

新興国市場におけるコールドチェーンインフラの拡大と、カーボンフットプリントを最小化するためのより持続可能でエネルギー効率の高い技術の開拓に大きな機会があります。バイオセンシング・パッケージングとブロックチェーンをベースとしたトレーサビリティ・ソリューションのイノベーションには、サプライチェーンの透明性と安全性を高める余地があります。市場関係者は、物流コスト削減のための予知保全やルート最適化のためのAIや機械学習の進歩も模索すべきです。課題としては、熟練労働力の格差への対応、品質と安全性のコンプライアンスを確保しつつ急速な技術革新への適応などが挙げられます。業界参加者は、研修・開発プログラムに投資し、次世代技術を活用するためにハイテク企業とのパートナーシップを育むべきです。堅牢で適応可能な戦略と持続可能な実践に焦点を当てることで、企業は急成長する機会を活用し、市場でのポジショニングを確固たるものにすることができます。環境に優しい素材や、費用対効果に優れ、拡張性のあるソリューションの継続的な調査により、このダイナミックな情勢における回復力と競合情勢を確実にすることができます。

市場力学：急速に進化するコールドチェーン医薬品市場の主要市場インサイトを公開

コールドチェーン医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 温度に敏感な医薬品や製品の保管需要の増加
  • 医薬品の保管と輸送に関する政府の厳しい規制
  • 研究開発活動に対する政府の取り組みの増加
• 市場抑制要因
  • 冷蔵倉庫の建設とメンテナンスにかかるコストの高さ
• 市場機会
  • ワクチン開発、モノクローナル抗体、生物製剤の進歩
  • 医薬品コールドチェーンにおけるIoTとブロックチェーンの統合
• 市場の課題
  • 医薬品コールドチェーンロジスティクスの運用の複雑さと熟練した専門家の不足

ポーターの5つの力：コールドチェーン医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コールドチェーン医薬品市場における外部からの影響の把握

外部マクロ環境要因は、コールドチェーン医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コールドチェーン医薬品市場における競合情勢の把握

コールドチェーン医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコールドチェーン医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コールドチェーン医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コールドチェーン医薬品市場における成功への道筋を描く

コールドチェーン医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 温度に敏感な医薬品や製品の保管に対する需要の増加
    • 医薬品の保管と輸送に関する厳格な政府規制
    • 研究開発活動に対する政府の取り組みの強化
  • 抑制要因
    • 冷蔵保管エリアの実施とメンテナンスのコストが高い
  • 機会
    • ワクチン開発、モノクローナル抗体、生物製剤の進歩
    • 医薬品コールドチェーンにおけるIoTとブロックチェーンの統合
  • 課題
    • 医薬品コールドチェーン物流の運用上の複雑さと熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コールドチェーン医薬品市場製薬製品

• 生物学的製剤
• 市販薬
• 処方薬
• 原材料および医薬品原薬

第7章 コールドチェーン医薬品市場：サービス別

• 交通機関
• 倉庫管理とVAS

第8章 コールドチェーン医薬品市場温度範囲別

• 常温
• 冷蔵
  • 冷凍
  • 液相液体窒素条件
  • 超冷凍
  • 気相液体窒素

第9章 コールドチェーン医薬品市場交通機関

• 航空路
• 道
• シーウェイズ

第10章 南北アメリカのコールドチェーン医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のコールドチェーン医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのコールドチェーン医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
• AmerisourceBergen Corporation
• Cavalier Logistics, Inc. by Mitsubishi Logistics
• Continental AG
• CWT Ltd.
• DB Schenker
• Deutsche Post AG
• DHL International GmbH
• FedEx Corporation
• HCL Technologies Limited
• Helapet ltd.
• JWD InfoLogistics Public Co. Ltd.
• Keppel Telecommunications & Transportation Ltd,
• Kerry Logistics Network Limited by SF Holding Co., Ltd.
• Kuehne+Nagel Management AG
• OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
• SCG Logistics Management Co Ltd.
• Tiong Nam Logistics Holdings Berhad
• United Parcel Service, Inc.
• VersaCold Logistics Services
• WHA Group
• Ych Group
• Yusen Logistics Group

LIST OF FIGURES

• FIGURE 1. COLD-CHAIN PHARMA MARKET RESEARCH PROCESS
• FIGURE 2. COLD-CHAIN PHARMA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COLD-CHAIN PHARMA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COLD-CHAIN PHARMA MARKET DYNAMICS
• TABLE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OVER-THE-COUNTER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRESCRIBED DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RAW MATERIALS & BULK PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY WAREHOUSING & VAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AMBIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LIQUID-PHASE LIQUID NITROGEN CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-FROZEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VAPOUR-PHASE LIQUID NITROGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR-WAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROAD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SEA-WAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 47. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 74. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 75. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 79. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 161. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 165. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 181. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 185. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 186. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 190. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 236. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023

The Cold-chain Pharma Market was valued at USD 7.89 billion in 2023, expected to reach USD 8.85 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 18.18 billion by 2030.

The cold-chain pharma market encompasses the logistics, storage, and transportation systems designed to maintain pharmaceutical products at designated low temperatures. Its necessity is rooted in preserving the efficacy and quality of temperature-sensitive drugs, vaccines, and biologics. Critical applications include vaccine distribution, biopharmaceuticals, and clinical trial materials, with end-users ranging from hospitals to research labs and retail pharmacies. The market is forecasted for substantial growth driven by increased global demand for biopharmaceuticals and complex biologics, coupled with heightened attention to regulatory compliance and quality standards. The rising prevalence of chronic diseases and the global push for immunization contribute significantly to this growth, alongside technological advancements in IoT and AI-powered monitoring systems aiding real-time data tracking and predictive analytics. However, the sector faces limitations such as high operational costs, limited infrastructure in developing regions, and stringent regulatory landscapes, which pose challenges to seamless expansion.

A substantial opportunity lies in expanding the cold chain infrastructure in emerging markets and developing more sustainable, energy-efficient technologies to minimize carbon footprints. There is an opening for innovation in biosensing packaging and blockchain-based traceability solutions, offering enhanced supply chain transparency and security. Market players should also explore advancements in AI and machine learning for predictive maintenance and route optimization to reduce logistics costs. Challenges include addressing the gap in skilled workforce and adapting to rapid technological changes while ensuring quality and safety compliance. Industry participants should invest in training and development programs and foster partnerships with tech firms to leverage next-gen technologies. By focusing on robust, adaptable strategies and sustainable practices, businesses can capitalize on burgeoning opportunities to solidify market positioning. Continuous research into eco-friendly materials and cost-effective, scalable solutions will ensure resilience and competitiveness in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold-chain Pharma Market

The Cold-chain Pharma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for storage of temperature-sensitive drugs and products
  • Stringent government regulations for pharmaceutical product storage and transportation
  • Increasing government initiatives for R&D activities
• Market Restraints
  • High cost of execution for cold storage areas and maintenance
• Market Opportunities
  • Advancement in vaccine development, monoclonal antibodies, and biologics
  • Integration of IoT and blockchain in pharma cold chain
• Market Challenges
  • Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Cold-chain Pharma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold-chain Pharma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold-chain Pharma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold-chain Pharma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold-chain Pharma Market

A detailed market share analysis in the Cold-chain Pharma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold-chain Pharma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold-chain Pharma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold-chain Pharma Market

A strategic analysis of the Cold-chain Pharma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold-chain Pharma Market, highlighting leading vendors and their innovative profiles. These include AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S, AmerisourceBergen Corporation, Cavalier Logistics, Inc. by Mitsubishi Logistics, Continental AG, CWT Ltd., DB Schenker, Deutsche Post AG, DHL International GmbH, FedEx Corporation, HCL Technologies Limited, Helapet ltd., JWD InfoLogistics Public Co. Ltd., Keppel Telecommunications & Transportation Ltd,, Kerry Logistics Network Limited by SF Holding Co., Ltd., Kuehne + Nagel Management AG, OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited, SCG Logistics Management Co Ltd., Tiong Nam Logistics Holdings Berhad, United Parcel Service, Inc., VersaCold Logistics Services, WHA Group, Ych Group, and Yusen Logistics Group.

Market Segmentation & Coverage

This research report categorizes the Cold-chain Pharma Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Pharma Product, market is studied across Biologics, Over-the-Counter Medicines, Prescribed Drugs, and Raw Materials & Bulk Pharmaceuticals.
• Based on Services, market is studied across Transportation and Warehousing & VAS.
• Based on Temperature Range, market is studied across Ambient and Refrigerated. The Refrigerated is further studied across Frozen, Liquid-Phase Liquid Nitrogen Conditions, Ultra-Frozen, and Vapour-Phase Liquid Nitrogen.
• Based on Transportation, market is studied across Air-ways, Road, and Sea-Ways.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for storage of temperature-sensitive drugs and products
    • 5.1.1.2. Stringent government regulations for pharmaceutical product storage and transportation
    • 5.1.1.3. Increasing government initiatives for R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of execution for cold storage areas and maintenance
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in vaccine development, monoclonal antibodies, and biologics
    • 5.1.3.2. Integration of IoT and blockchain in pharma cold chain
  • 5.1.4. Challenges
    • 5.1.4.1. Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cold-chain Pharma Market, by Pharma Product

• 6.1. Introduction
• 6.2. Biologics
• 6.3. Over-the-Counter Medicines
• 6.4. Prescribed Drugs
• 6.5. Raw Materials & Bulk Pharmaceuticals

7. Cold-chain Pharma Market, by Services

• 7.1. Introduction
• 7.2. Transportation
• 7.3. Warehousing & VAS

8. Cold-chain Pharma Market, by Temperature Range

• 8.1. Introduction
• 8.2. Ambient
• 8.3. Refrigerated
  • 8.3.1. Frozen
  • 8.3.2. Liquid-Phase Liquid Nitrogen Conditions
  • 8.3.3. Ultra-Frozen
  • 8.3.4. Vapour-Phase Liquid Nitrogen

9. Cold-chain Pharma Market, by Transportation

• 9.1. Introduction
• 9.2. Air-ways
• 9.3. Road
• 9.4. Sea-Ways

10. Americas Cold-chain Pharma Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cold-chain Pharma Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cold-chain Pharma Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
• 2. AmerisourceBergen Corporation
• 3. Cavalier Logistics, Inc. by Mitsubishi Logistics
• 4. Continental AG
• 5. CWT Ltd.
• 6. DB Schenker
• 7. Deutsche Post AG
• 8. DHL International GmbH
• 9. FedEx Corporation
• 10. HCL Technologies Limited
• 11. Helapet ltd.
• 12. JWD InfoLogistics Public Co. Ltd.
• 13. Keppel Telecommunications & Transportation Ltd,
• 14. Kerry Logistics Network Limited by SF Holding Co., Ltd.
• 15. Kuehne + Nagel Management AG
• 16. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
• 17. SCG Logistics Management Co Ltd.
• 18. Tiong Nam Logistics Holdings Berhad
• 19. United Parcel Service, Inc.
• 20. VersaCold Logistics Services
• 21. WHA Group
• 22. Ych Group
• 23. Yusen Logistics Group